Middle-East Endocrine, Diabetes and Obesity Congress Opens in Jeddah

The Middle-East Endocrine, Diabetes and Obesity Congress commenced in Jeddah on February 7, 2025, under the theme “Beyond Weight Loss,” bringing together international specialists to address the latest advancements in diagnosing and treating diabetes and obesity. Organized by the Saudi Scientific Diabetes Society, the four-day event underscores the Kingdom’s commitment to combating chronic diseases through knowledge exchange and innovation.

Context and Background

Diabetes and obesity represent major public health challenges globally, with the Middle East experiencing high prevalence rates. Saudi Arabia has prioritized healthcare transformation as a key pillar of Vision 2030, aiming to enhance quality of life and reduce the burden of non-communicable diseases. The congress serves as a platform for regional and international experts to collaborate on evidence-based solutions, aligning with the Kingdom’s goal to become a leader in healthcare innovation.

Key Details

The conference covers critical topics including prevention strategies, modern treatment technologies, and the latest scientific research on diabetes and obesity. Interactive workshops and scientific sessions are designed to improve healthcare practices across the Middle East by fostering skill development among professionals. Breakthroughs in diagnosis, pharmacological and surgical treatments, and sustainable solutions are highlighted, showcasing future trends in endocrine care.

Implications and Impact

By hosting such congresses, Saudi Arabia reinforces its role as a regional hub for medical excellence and international cooperation. The knowledge shared is expected to directly influence clinical practices and health policies in the Middle East, contributing to better patient outcomes. This initiative also supports the global fight against obesity and diabetes, positioning the Kingdom as a proactive partner in addressing pressing health challenges.

Vision 2030 Alignment

The congress directly supports Vision 2030‘s objective of improving healthcare and quality of life for Saudi citizens and residents. By investing in medical research, professional training, and international partnerships, the Kingdom is building a sustainable healthcare ecosystem that will reduce the socioeconomic impact of chronic diseases. This event exemplifies Saudi Arabia’s commitment to becoming a global leader in health innovation and a model for preventive care.

20 Questions

Q1. What is the Middle-East Endocrine, Diabetes and Obesity Congress?

A1. It is a four-day event organized by the Saudi Scientific Diabetes Society, held in Jeddah, focusing on the latest advancements in diagnosing and treating diabetes and obesity under the theme “Beyond Weight Loss.”

Q2. When and where did the congress begin?

A2. The congress began on February 7, 2025, in Jeddah, Saudi Arabia, bringing together international specialists and experts in diabetes and obesity.

Q3. Who organized the congress?

A3. The congress was organized by the Saudi Scientific Diabetes Society, a recognized Saudi medical organization dedicated to diabetes research and education.

Q4. What is the theme of the congress?

A4. The theme is “Beyond Weight Loss,” emphasizing a comprehensive approach to treating obesity and diabetes beyond mere weight reduction.

Q5. What are the main topics of discussion?

A5. Key topics include prevention strategies, modern treatment technologies, latest scientific research, and health and psychological impacts of diabetes and obesity.

Q6. What types of sessions are offered?

A6. Interactive workshops and scientific sessions are offered, aimed at enhancing healthcare practices through knowledge exchange and skill development.

Q7. Why is this congress important for Saudi Arabia?

A7. It supports Vision 2030’s healthcare transformation goals by fostering innovation, collaboration, and professional development to combat chronic diseases.

Q8. How does the congress benefit the Middle East region?

A8. It enhances healthcare practices across the Middle East by sharing best practices, advanced treatments, and fostering regional cooperation among professionals.

Q9. What breakthroughs are highlighted at the congress?

A9. Breakthroughs in diagnosis, pharmacological and surgical treatments, sustainable solutions, and future trends in obesity and diabetes care are highlighted.

Q10. Who are the attendees of the congress?

A10. Specialists, experts, healthcare professionals, and researchers from around the world in the fields of endocrinology, diabetes, and obesity attend.

Q11. What is the role of the Saudi Scientific Diabetes Society?

A11. It is the organizer, promoting diabetes education, research, and clinical excellence within Saudi Arabia and internationally.

Q12. How does the congress align with global health priorities?

A12. It addresses the global epidemic of diabetes and obesity by sharing cutting-edge research and fostering international cooperation to improve patient outcomes.

Q13. Does the congress include surgical treatments?

A13. Yes, it showcases advanced pharmacological and surgical treatments for obesity and diabetes, including modern therapeutic innovations.

Q14. What is the duration of the congress?

A14. The congress lasts four days, from February 7 to 10, 2025, packed with sessions and workshops.

Q15. How does this event support Vision 2030?

A15. It directly supports Vision 2030’s healthcare pillar by improving quality of life, reducing chronic disease burden, and positioning Saudi Arabia as a health innovation leader.

Q16. Are there interactive elements for attendees?

A16. Yes, interactive workshops allow hands-on learning and skill development for healthcare professionals attending the congress.

Q17. What future trends are discussed?

A17. Future trends include sustainable treatment solutions, advanced therapies, and integrated approaches to managing diabetes and obesity.

Q18. How does the congress promote knowledge exchange?

A18. Through scientific sessions and workshops where experts share research findings, clinical experiences, and best practices in the field.

Q19. What is the significance of the congress location?

A19. Holding it in Jeddah, a major Saudi city, highlights the Kingdom’s commitment to hosting international medical events and fostering regional collaboration.

Q20. How can healthcare professionals benefit from attending?

A20. Attendees gain updated knowledge on diagnosis, treatment, and prevention; develop new skills; and network with leading experts to improve patient care.

---